
Sign up to save your podcasts
Or


Why was 2019 so rough for the cannabis industry? How can investors make better sense of the FDA approval process for drugmakers? Shannon Jones analyzes two of the most interesting industries for investors and shares what to watch in 2020 and beyond.
Thanks Health IQ. See if you qualify for lower rates! Go to www.healthiq.com/fool.
By The Motley Fool4.7
16041,604 ratings
Why was 2019 so rough for the cannabis industry? How can investors make better sense of the FDA approval process for drugmakers? Shannon Jones analyzes two of the most interesting industries for investors and shares what to watch in 2020 and beyond.
Thanks Health IQ. See if you qualify for lower rates! Go to www.healthiq.com/fool.

3,223 Listeners

1,500 Listeners

806 Listeners

948 Listeners

522 Listeners

1,180 Listeners

2,171 Listeners

827 Listeners

1,418 Listeners

1,039 Listeners

9,628 Listeners

192 Listeners

810 Listeners

79 Listeners

40 Listeners

985 Listeners

43 Listeners